Mark Kirschbaum Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity
Mark Kirschbaum is Chief Medical Officer of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 31,200 shares of CYCC, which is worth approximately $19,656. The most recent transaction as insider was on Jan 31, 2023, when has been sold 31,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
31.2K
0%
3M change
0%
12M change
Total Value Held
$19,656
MK
Mark Kirschbaum
Chief Medical Officer
Berkeley Heights, NJ